PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
28.05.24
/
50%
€33.60
Target price
28.05.25
€29.42
Performance (%)
0.60%
Price
27.09.24
€33.00
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc. is nearly unchanged. This prediction currently runs until 28.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 1.227% | 1.227% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€29.48
21.05.25
21.05.25
-4.00%
27.09.24
27.09.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€20.61
18.09.24
18.09.24
40.35%
19.09.24
19.09.24